PERFUSION SYSTEMS AFFINITY CP PUMP; PUMP, BLOOD, CARDIOPULMONARY BYPASS, NON-ROLLER TYPE
|
Back to Search Results |
|
Model Number BBAP40 |
Device Problems
Insufficient Flow or Under Infusion (2182); Noise, Audible (3273)
|
Patient Problems
Cardiac Arrest (1762); Ischemia (1942)
|
Event Date 07/22/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Device evaluation summary: the device was returned bloody with clots throughout the device and as the device was being cleaned there was evidence of clotting around the upper pivot bearing.Visual inspection shows the impeller is loose inside the housing.Additional visual inspection shows evidence of deformity at the upper pivot bearing.Performance analysis: the device was run on a bio console from 0-4000 rpm¿s, a noise level greater than 80 db was recorded, a rattling noise was noted; specification is less than 68 db.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that during use of a bbap40 affinity cp centrifugal blood pump, a code blue in the patient's icu room was reported.A loud grinding noise was heard coming from the pump and the blood flow was noted to be 0.126 lpm.The perfusionist quickly got another ecmo pump and full setup and brought it into the room.At 1554 the patient was placed back on full vv ecmo with a blood flow of 5.76 lpm.The patient was following staff commands once the code blue was over and they were back on full ecmo support.The patient experienced very low blood flow and cpr was administered during this incident.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
H.6 fdp patient code updated.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|